Biotronik SE & Co. KG has begun the US launch of the PK Papyrus balloon-expandable covered stent for treating acute perforations of native coronary arteries and coronary bypass grafts.
The US Food & Drug Administration granted a humanitarian device exemption (HDE) for PK Papyrus in September 2018. The FDA said it is the first device it has approved...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?